Biopol Chemicals Limited (NSE:BIOPOL)
India flag India · Delayed Price · Currency is INR
42.10
-3.75 (-8.18%)
At close: Oct 23, 2026

Biopol Chemicals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Revenue
811.43811.43492.21174.33
Revenue Growth
-64.85%182.35%-
Gross Profit
180.17180.1789.1827.91
Operating Income
134.27134.2763.9218.38
Net Income
89.7489.7443.1212.81
Earnings Per Share
10.8310.835.45-
EPS Growth
-98.72%--

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Cash & Investments
5.185.1811.480.82
Total Debt
84.6584.6576.8535.77
Net Cash (Debt)
-79.47-79.47-65.37-34.94
Net Cash Growth
----
Net Cash Per Share
-9.59-9.59-8.26-

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Operating Cash Flow
-127.66-127.66-24.14-88.72
Capital Expenditures
-142-142-0.24-0.71
Free Cash Flow
-269.66-269.66-24.38-89.43
Free Cash Flow Growth
----

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Gross Margin
22.20%22.20%18.12%16.01%
Operating Margin
16.55%16.55%12.99%10.54%
Pretax Margin
14.86%14.86%11.74%9.82%
Profit Margin
11.06%11.06%8.76%7.35%
FCF Margin
-33.23%-33.23%-4.95%-51.30%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingOct '26 Mar '26 Mar '25 Mar '24
PE Ratio
3.8911.69--
PS Ratio
0.611.29--